Back to News
Market Impact: 0.15

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

PFE
TGT
Analyst EstimatesAnalyst InsightsCompany Fundamentals
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Pfizer (PFE) is trading at $24.25 versus a Wall Street consensus price target of $28.79, implying nearly 19% upside. The update is analyst-target driven and suggests modest positive sentiment rather than a catalyst with immediate broad market impact.

Analysis

Pfizer (PFE) is trading at $24.25 versus a Wall Street consensus price target of $28.79, implying nearly 19% upside. The update is analyst-target driven and suggests modest positive sentiment rather than a catalyst with immediate broad market impact.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25

Ticker Sentiment

PFE0.20
TGT0.00